Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 272

1.

Insulin resistance as a predictor of cardiovascular disease in patients on peritoneal dialysis.

Li Y, Zhang L, Gu Y, Hao C, Zhu T.

Perit Dial Int. 2013 Jul-Aug;33(4):411-8. doi: 10.3747/pdi.2012.00037. Epub 2013 Mar 1.

2.

Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease.

Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y.

J Am Soc Nephrol. 2002 Jul;13(7):1894-900.

3.

Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study.

Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D; MMKD Study Group.

J Am Soc Nephrol. 2005 Apr;16(4):1091-8. Epub 2005 Mar 2.

4.

Impact of arterial stiffness on adverse cardiovascular outcomes and mortality in peritoneal dialysis patients.

Sipahioglu MH, Kucuk H, Unal A, Kaya MG, Oguz F, Tokgoz B, Oymak O, Utas C.

Perit Dial Int. 2012 Jan-Feb;32(1):73-80. doi: 10.3747/pdi.2010.00186. Epub 2011 Mar 31.

5.

Insulin resistance negatively affects long-term outcome in non-diabetic patients with coronary artery disease after therapies to reduce atherosclerotic risk factors.

Kitta Y, Nakamura T, Uematsu M, Sugamata W, Deyama J, Fujioka D, Saito Y, Kawabata K, Obata JE, Kugiyama K.

J Cardiol. 2013 Dec;62(6):348-53. doi: 10.1016/j.jjcc.2013.05.006. Epub 2013 Jul 1.

6.
8.

The relationship of visfatin levels with insulin resistance and left ventricular hypertrophy in peritoneal dialysis patients.

Karakan S, Sezer S, Özdemir Acar FN, Haberal M.

Ren Fail. 2012;34(6):732-7. doi: 10.3109/0886022X.2012.676493. Epub 2012 Apr 16.

PMID:
22503095
9.

Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study.

Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M.

Diabetes Care. 2007 Feb;30(2):318-24.

PMID:
17259501
10.

Insulin resistance is associated with circulating fibrinogen levels in nondiabetic patients receiving peritoneal dialysis.

Martins C, Mazza do Nascimento M, Pecoits-Filho R, Leinig C, Gonçalves LF, Fuerbringer R, Stenvinkel P, Lindholm B, Riella MC.

J Ren Nutr. 2007 Mar;17(2):132-7.

PMID:
17321953
11.

Insulin resistance is associated with new-onset cardiovascular events in nondiabetic patients undergoing peritoneal dialysis.

Yoon CY, Lee MJ, Kee YK, Lee E, Joo YS, Han IM, Han SG, Oh HJ, Park JT, Han SH, Kang SW, Yoo TH.

Kidney Res Clin Pract. 2014 Dec;33(4):192-8. doi: 10.1016/j.krcp.2014.10.002. Epub 2014 Dec 3.

12.

HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.

Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Cacciatori V, Santi L, Targher G, Bonadonna R, Muggeo M.

Diabetes Care. 2002 Jul;25(7):1135-41.

PMID:
12087010
13.

Repeated analysis of estimated insulin resistance using the HOMAIR index in nondiabetic patients on peritoneal dialysis and its relationship with cardiovascular disease and mortality.

Sánchez-Villanueva R, Estrada P, del Peso G, Grande C, Díez JJ, Iglesias P, González E, Aguilar-Rodríguez A, Selgas R, Bajo MA; Grupo de Estudios Peritoneales de Madrid de REDINREN (Red Renal de Investigación de la RETICS 06/0016, del Instituto de Salud Carlos III); del IRSIN (Instituto Reina Sofía de Investigación Nefrológica).

Nefrologia. 2013 Jan 18;33(1):85-92. doi: 10.3265/Nefrologia.pre2012.Nov.11430. English, Spanish.

14.

C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.

Jeppesen J, Hansen TW, Olsen MH, Rasmussen S, Ibsen H, Torp-Pedersen C, Hildebrandt PR, Madsbad S.

Eur J Cardiovasc Prev Rehabil. 2008 Oct;15(5):594-8. doi: 10.1097/HJR.0b013e328308bb8b.

PMID:
18753952
15.

Association of insulin resistance with arterial stiffness in nondiabetic peritoneal dialysis patients.

Tatar E, Demirci MS, Kircelli F, Gungor O, Turan MN, Sevinc Ok E, Asci G, Ozkahya M, Ok E.

Int Urol Nephrol. 2012 Feb;44(1):255-62. doi: 10.1007/s11255-011-9984-z. Epub 2011 Jun 4.

PMID:
21643643
16.
17.

Hypovitaminosis D and insulin resistance in peritoneal dialysis patients.

Bindal ME, Taskapan H.

Int Urol Nephrol. 2011 Jun;43(2):527-34. doi: 10.1007/s11255-010-9813-9. Epub 2010 Jul 29.

PMID:
20668935
18.
19.

Waist-to-height ratio: an accurate anthropometric index of abdominal adiposity and a predictor of high HOMA-IR values in nondialyzed chronic kidney disease patients.

Silva MI, Lemos CC, Torres MR, Bregman R.

Nutrition. 2014 Mar;30(3):279-85. doi: 10.1016/j.nut.2013.08.004. Epub 2013 Dec 12.

PMID:
24332526
20.

Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease.

Tenenbaum A, Adler Y, Boyko V, Tenenbaum H, Fisman EZ, Tanne D, Lapidot M, Schwammenthal E, Feinberg MS, Matas Z, Motro M, Behar S.

Am Heart J. 2007 Apr;153(4):559-65.

PMID:
17383294
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk